Skip to main content
Smart Investors Daily
SW

NASDAQ · SWKHL

SWK Holdings Corporation 9.00% Senior Notes due 2027

Financial Services · Asset Management

$25.14

Down-$0.43 (-1.68%)

Updated Sep 16, 2026, 11:57 AM

SID Score

4.4/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
180.59M
P/E ratio
12.18
Dividend yield
8.96%
52-week range
$24.34 – $25.79
Volume
8.57K
Avg. volume
2.82K

Price performance

SWKHL price history

1M range · 19 trading sessions · Daily adjusted prices

SWKHL closed at $25.14 after 19 trading sessions, down 1.06% for the selected period.

Last close
$25.14
Period change
-1.06%
Period low
$25.14
Period high
$25.59
Daily close
View OHLC price history
SWKHL OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 15, 2026$25.02$25.14$25.02$25.148.57K
Sep 14, 2026$25.51$25.57$25.51$25.573.66K
Sep 11, 2026$25.54$25.59$25.49$25.58991.98K
Sep 10, 2026$25.54$25.54$25.47$25.5057.26K
Sep 9, 2026$25.50$25.54$25.50$25.53994.08K
Sep 8, 2026$25.49$25.51$25.47$25.496.86K
Sep 4, 2026$25.48$25.56$25.48$25.563.22K
Sep 2, 2026$25.48$25.48$25.45$25.45991.53K
Sep 1, 2026$25.47$25.48$25.47$25.48229
Aug 31, 2026$25.48$25.48$25.44$25.4401636
Aug 28, 2026$25.45$25.48$25.41$25.42042.34K
Aug 27, 2026$25.45$25.45$25.42$25.42011.56K
Aug 26, 2026$25.45$25.45$25.44$25.441.49K
Aug 25, 2026$25.43$25.45$25.43$25.4499626
Aug 24, 2026$25.44$25.44$25.415$25.43618
Aug 21, 2026$25.45$25.45$25.425$25.425293
Aug 20, 2026$25.45$25.45$25.45$25.451.38K
Aug 19, 2026$25.44$25.44$25.44$25.441.02K
Aug 18, 2026$25.46$25.46$25.41$25.412.15K

Latest SWKHL news

The latest Smart Investors Daily articles mentioning SWKHL.

SWKHL research

Overview

Company profile and research snapshot.

Company profile

SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.